Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DSIW85
|
|||
| Drug Name |
OPC-64005
|
|||
| Indication | Attention deficit hyperactivity disorder [ICD-11: 6A05.Z; ICD-9: 314] | Phase 2 | [1] | |
| Company |
Otsuka Pharmaceutical
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Serotoninnorepinephrinedopamine reuptake (SNDR) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03324581) The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Otsuka Pharmaceutical. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.